about
Botulinum toxins for the prevention of migraine in adultsThe cerebellum and migraineCalcitonin gene-related peptide (CGRP) receptor antagonists in the treatment of migraineMutation I810N in the alpha3 isoform of Na+,K+-ATPase causes impairments in the sodium pump and hyperexcitability in the CNS.Calcitonin gene-related peptide stimulation of nitric oxide synthesis and release from trigeminal ganglion glial cellsThe Influence of Na(+), K(+)-ATPase on Glutamate Signaling in Neurodegenerative Diseases and SenescenceMolecular factors in migraineCortical inhibition and habituation to evoked potentials: relevance for pathophysiology of migraine.Genetic and hormonal factors modulate spreading depression and transient hemiparesis in mouse models of familial hemiplegic migraine type 1.Identification of cytokines and signaling proteins differentially regulated by sumatriptan/naproxen.Increased susceptibility to cortical spreading depression in the mouse model of familial hemiplegic migraine type 2.Familial hemiplegic migraine.Whole isolated neocortical and hippocampal preparations and their use in imaging studies.Insights into migraine mechanisms and CaV2.1 calcium channel function from mouse models of familial hemiplegic migraine.Calcium channels and synaptic transmission in familial hemiplegic migraine type 1 animal models.Headache-type adverse effects of NO donors: vasodilation and beyondCentral sensitization in the trigeminal nucleus caudalis produced by a conjugate of substance P and the A subunit of cholera toxin.Carnosine treatment for gulf war illness: a randomized controlled trialLocalization of CGRP receptor components, CGRP, and receptor binding sites in human and rhesus cerebellar cortex.[Transcranial magnetic stimulation (TMS) in basic and clinical neuroscience research].Shared genetic factors in migraine and depression: evidence from a genetic isolate.Spreading depression transiently disrupts myelin via interferon-gamma signaling.Calcitonin gene-related peptide differentially regulates gene and protein expression in trigeminal glia cells: findings from array analysis.Tonabersat inhibits trigeminal ganglion neuronal-satellite glial cell signaling.DHE repression of ATP-mediated sensitization of trigeminal ganglion neurons.Regulation of voltage-gated calcium channels by proteolysis.Epigenetic regulation of the calcitonin gene-related peptide gene in trigeminal glia.The effect of 17β-estradiol on gene expression of calcitonin gene-related peptide and some pro-inflammatory mediators in peripheral blood mononuclear cells from patients with pure menstrual migraine.Sumatriptan does not change calcitonin gene-related peptide in the cephalic and extracephalic circulation in healthy volunteersNeuron-glia signaling in trigeminal ganglion: implications for migraine pathology.Glial calcium signaling in physiology and pathophysiology.Two mechanisms involved in trigeminal CGRP release: implications for migraine treatment.Presynaptic CaV2.1 calcium channels carrying familial hemiplegic migraine mutation R192Q allow faster recovery from synaptic depression in mouse calyx of Held.Genetic biomarkers for migraine.Preventive agents for migraine: focus on the antiepileptic drugs.The biology of the glutamatergic system and potential role in migraine.Topiramate: safety and efficacy of its use in the prevention and treatment of migraine.Apnoeic spells following general anaesthesia in a patient with familial hemiplegic migraine.Cortical spreading depression and estrogen.Effect of amitriptyline on tetrodotoxin-resistant Nav1.9 currents in nociceptive trigeminal neurons.
P2860
Q24186932-94A982A1-CFCB-448E-A32B-AF98CCBC35D8Q24628942-8652B089-9842-4DB9-9E53-38E994497C5CQ24632671-B740036E-E351-409A-8375-BC22E241D302Q24649570-8E698386-4851-471B-8C06-D8C35A44EFC0Q24652416-66BF6E02-1613-47A4-B832-DE1ABE4D0D86Q26745558-E95B1053-5986-414E-8F09-900248509C63Q28078828-E31CC7E0-B3A1-4F23-A524-78DC22022667Q30460443-856A8883-5192-4362-A8C5-BD09A8A61C82Q30485295-628775B5-7161-45FC-B6D1-B651DF2B30D9Q30505261-47B9DE71-B824-4FB9-9B80-6B3A58797863Q31022226-A68A6BAB-76B8-43B5-A520-2B1585928AC8Q33280531-5F5CB79F-34EE-4EE7-8701-EAD353143D6EQ33296370-9E8B1ED4-8963-4BD3-BFBC-9777F979408EQ33535616-34468268-3404-4DA8-9A92-C8B18C8058B1Q33680269-4FA3D522-BFC4-4528-8C57-58AC67F522F6Q33812736-72B15BA2-C3EA-4738-B5AE-41ED4499F053Q34091843-433E3AFC-6AD5-4432-810B-5336DC613DD8Q34403718-4DC7FB0F-383D-4F04-A78B-EA6B64A32A90Q34897152-68A5A38B-F77F-4A14-B042-8C3E47BC919BQ34976531-0246FFB3-42CB-47A3-8B57-91280F57DBBDQ35065444-92618CF0-CD20-4CB5-9F5E-AAB9285D8D9EQ35071478-BCBC1D6E-C264-4FA1-AA52-D527C6F7FC47Q35090192-0129517F-1CBC-4494-9E22-4AAE9AC9E9E6Q35110494-74C8DA7B-6F9D-4BE5-9DD7-D89A32DBC327Q35110498-BF356254-56AD-4262-8B79-7549783251F0Q35166587-8E6EA36C-61A9-496B-8E69-E4AD60045AE2Q36060346-DF7EC6C8-A278-4298-AFBC-B9D16611D8D1Q36205196-4CD0AD9B-8916-4C60-8DEE-9D4D144A7253Q36259595-914B47FC-BBF7-4355-B96C-C2AFE2FFD3F8Q36498875-3360FC9A-9BD2-4F2B-AE92-0014B8DD1047Q36513329-3EA70E8A-55B1-4C88-84B2-B29F37581798Q36518248-FE3E7EE4-4BD4-4479-974A-98584173F908Q36531989-6C7BE61E-A597-43C8-9E35-FAA252C62598Q36546354-D1FC22D8-E6A4-4BE7-93B4-CCA9900D5C89Q36748706-41210C6E-AC11-4CC7-8675-BF77E9492BAEQ36816562-35A6E1E6-7325-46AA-ABE6-9A5B51F31CF2Q36873926-B413665C-81F0-450B-ADDD-707186013C0AQ36909596-44BBCF72-8CAD-4011-B927-9ABEA9AE2635Q36938678-7B624D43-0300-44D1-8DAB-4C6FA6B14950Q36953269-F72AEE63-16CD-4636-889E-328965F2E0A4
P2860
description
2005 nî lūn-bûn
@nan
2005 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Migraine: new molecular mechanisms.
@ast
Migraine: new molecular mechanisms.
@en
type
label
Migraine: new molecular mechanisms.
@ast
Migraine: new molecular mechanisms.
@en
prefLabel
Migraine: new molecular mechanisms.
@ast
Migraine: new molecular mechanisms.
@en
P2860
P356
P1433
P1476
Migraine: new molecular mechanisms.
@en
P2093
Daniela Pietrobon
P2860
P304
P356
10.1177/1073858405275554
P577
2005-08-01T00:00:00Z